SU311163A1
(https= )
RU2010125312A
(ru )
2012-02-20
Моющие средства, имеющие приемлемую окраску
DK0721777T3
(da )
2002-10-07
Anvendelse af tomoxetin til behandling af uopmærksomheds/hyperaktivitetssygdom
ATE226193T1
(de )
2002-11-15
Substituierte zyklische amine als metalloproteaseinhibitoren
ATE342973T1
(de )
2006-11-15
Zusammensetzungen von durch niedervolt aktivierten kalziumkanälen und verfahren
MX2024014322A
(es )
2024-12-06
Purificacion de un flujo de alcohol etilenicamente insaturado, preparacion de un aldehido etilenicamente insaturado, en particular, prenal, y compuestos derivados de estos
CL2025001654A1
(es )
2025-07-04
Compuestos novedosos como moduladores de la inhibición de nlrp3
EP4420489A4
(en )
2025-11-05
ALL-OPTICAL LIGHT SOURCE CONTROLLED BY LASER WITH ELECTRODE-FREE IGNITION
Masse et al.
1997
Asymmetric C− N Bond Constructions via Crotylsilane Addition Reactions: A Stereocontrolled Route to Dipeptide Isosteres
CL2025000484A1
(es )
2025-06-27
Compuestos deuterados de pirimidin-2-il sulfonamida, uso para tratar trastornos desmielinizantes.
EA202190298A1
(ru )
2021-04-16
Циклические динуклеотиды в качестве агонистов sting
SU233058A1
(https= )
SU180764A1
(https= )
DE69912474D1
(de )
2003-12-04
Verfahren zur racematspaltung von tramadol
SU311177A1
(https= )
CO2022012773A2
(es )
2022-10-11
Moduladores de nampt
WO2023012481A3
(en )
2023-04-13
Method
Zhu et al.
2003
Efficient synthesis of differently protected lanthionines via β‐bromoalanine derivatives
EA202290086A1
(ru )
2022-03-18
СПОСОБ СТАБИЛИЗАЦИИ рН ВОДНОЙ КОМПОЗИЦИИ, СОДЕРЖАЩЕЙ ЛЕКАРСТВЕННОЕ СРЕДСТВО
SU236484A1
(https= )
TR199802529A2
(xx )
1999-06-21
Kullan�lm�� molibden esasl� katalizat�r performans�n�n amonyum dimolibdat ilave edilmesi yoluyla iyile�tirilmesi.
Liu et al.
2004
Derivatization of amino acids with N, N‐dimethyl‐2, 4‐dinitro‐5‐fluorobenzylamine for liquid chromatography/electrospray ionization mass spectrometry
SU236521A1
(https= )
MX2024005029A
(es )
2025-01-09
Un método para producir tequila
Aleksić et al.
2004
Polarographic and voltammetric behavior of the antibiotic cefetamet; Reduction of the methoxyimino group